Developing new treatments to combat bacterial resistance using biopharmaceuticals
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
This study is working on new treatments to help fight infections caused by bacteria that don't respond to regular medicines, using special tools like antibodies and RNA, to make sure patients have better options for getting better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-10934774 on NIH RePORTER |
What this research studies
This research focuses on the preclinical development of innovative biopharmaceutical products aimed at addressing bacterial drug resistance. It involves creating and evaluating various biological materials, including monoclonal antibodies and small interfering RNA (siRNA) vectors, to enhance treatment options for infectious diseases. The program provides comprehensive services such as product development planning, assay development, and regulatory support to ensure effective translation of these therapies from the lab to clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections that are resistant to standard antibiotic treatments.
Not a fit: Patients with infections that are easily treatable with existing antibiotics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Other research in the field of biopharmaceuticals and antibiotic resistance has shown promising results, indicating that this approach has potential for success.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.